to allow conclusions concerning molecular heterogeneity or homogeneity with regard to the distinct biological activities of AEF. In order to address this and other questions more directly, and to provide a more uniform source of AEF molecules for further purification and analysis, we have utilized the technique of somatic cell hybridization to construct T cell hybridomas secreting AEF. This report describes the characteristics of such hybridomas and the AEF secreted by them.
Materials and Methods
Mice. All inbred mice employed in these studies were obtained from the Scripps Clinic and Research Foundation (SCRF) mouse breeding colony, The Jackson Laboratory (Bar Harbor, Maine), or from Simonsen Laboratories (Gilroy, Calif.).
Preparation ofsAEF. AEF was prepared in the conventional manner as described previously (1, 9) . 1 × 10 thymoeytes from young (4-to 6-wk-old) DBA/2 donors were mixed with an equal number of irradiated (1,500 tad) spleen cells from (C3H × DBA/2) F1 hybrid mice (C3D2F1) and injected intravenously into irradiated (650 rad) DBA/2 recipient mice. The alloantigen-activated T cells recovered from the spleens of these mice 7 d later were co-cultured with fresh irradiated C3D2FI stimulator spleen cells. Responder and stimulator cells were pretreated with 10 p.g/ml phenylmethyisulphonyl fluoride to inhibit the activity of serine proteases that tend to degrade AEF (6) and cultured for 18-24 h at 1 x 107/ml each in serumfree RPMI-1640 medium (Grand Island Biological Co., Grand Island, N. Y.) supplemented with 1 × 10 -4 M 2-mercaptoethanol. Cultures were maintained in a Mishell-Dutton gas mixture on a rocking platform. The culture supernate was obtained by centrifugation (2,500 rpm, 15 rain), filter sterilized, and stored at -70°C until used.
Construction of AEF-secreting Hybridomas. T cell blasts activated to alloantigen in vivo and
secondarily stimulated in vitro as described above were recovered after 18 h in culture and separated in FicolI-Hypaque in Dulbecco's minimum essential medium (DMEM): phosphatebuffered saline solution prepared as described elsewhere (15) . Cells recovered from the interface after eentrifugation were predominantly blastlike in nature and were used for hybridization.
The parental cell line used for hybridization was the AKR-derived T cell line, BW 5147 obtained from Dr. Robert Hyman of The Salk Institute, La Jolla, Calif. This line is hypoxanthine guanine phosphoribosyl transferase negative, and displays the following cell surface phenotype (16) : H-2 k÷, Thy-l.1 +, Ig-, Ia-, Lyt-I +, Lyt-2-.
Cell fusion was performed according to Gefter et al. (17) with some modifications. Parental tumor cells were washed twice in DMEM, and 2 × 106 tumor cells were mixed with 1 X 107 activated T cell blasts. The cell suspension was centrifuged, and all medium was carefully removed by aspiration. The cell pellet was then resuspended in 0.2 ml of 30% polyethylene glycol 1,000 in DMEM. Cells remained in this solution for a total of 8 min, during which time they were centrifuged for 6 rain at 1,000 rpm (ambient temperature). At the end of 8 min, 5 ml of DMEM was added to the tube, and the cells were washed twice in this medium. They were resuspended in DMEM supplemented with 10% fetal calf serum (FCS) and incubated overnight at 37°C in a 10% CO2 in air atmosphere. The next day, the cells were pelleted by centrifugation and resuspended in 30 ml of FCS-supplemented DMEM containing hypoxanthine (1 × 10 -4 M), aminopterin (4 × 10 -6 M), and thymidine (1.6 × 10 -5 M), and were distributed into individual wells of 96-well flat-bottom microplates. Cultures were fed after 1 wk by the addition of one drop of this same medium without aminopterin.
Screening of hybridoma supernates was carried out by incorporating multiple dilutions of each given supernate tested into primary in vitro antibody responses to sheep erythrocytes (SRBC) or trinitrophenyl (TNP)-derivatized SRBC (see below).
Biological Assays for AEF Activity
tN VITRO ANTmOOV RESPONSE SYSTEm. AEF preparations and hybridoma supernates were tested for their ability to reconstitute primary in vitro antibody responses against SRBC or TNP-SRBC of anti-Thy 1.2 serum plus complement (C)-treated DBA/2 or A/J spleen cells. The methods for establishing such cultures and for analyzing the resulting SRBC-or TNPspecific plaque-forming cells (PFC) were identical with those described previously (1). CTL CULTURE SYSTEM. Spleen cell suspensions of normal, unprimed mice were prepared and depleted of erythrocytes by NH4CL treatment as described previously (9) . The cells were resuspended in Eagle-Hank's amino acid (EHAA) medium (18) supplemented with 5 × 10 -5 M 2-ME and 5% heat-inactivated FCS and cultured in Cluster ~ tissue culture plates (Microbiological Associates, Waikersville, Md.) at 7.5 X 106 ceils per well in 2 ml of medium containing various concentrations of AEF or hybridoma supernate as described in Results. The cultures were maintained for 5 d in a 5% CO2 incubator and then assayed for their cytolytic activity. The cytolytic activities in such cultures were determined using the Thy-56 lymphoma (BALB/c, H-2 d) labeled with 5XCr as described in detail elsewhere (19 Antisera and Cytolytic Depletion. Anti-Thy-l.l and Thy-l.2 antibodies were prepared as described in detail previously (21) . A.TL anti A.TH (anti-Ia 8) and B 10.A anti-B 10 (anti-l-A d) were prepared as previously described (13) . A similar immunization reffimen was used to prepare B10.BR anti-Bl0.D2 (anti-H-2 a) and BI0 anti-B10.BR (anti-H-2) antibodies. All of these reagents had titers of 1:1,000 or higher in a C-dependent microcytotoxicity assay (22) .
Analysis of cell surface phenotypes of hybridomas was carried out in a C-dependent microcytotoxicity assay previously described from this laboratory (22) .
Results

AEF-secreting T Cell Hybridomas Replace Helper T Cells in Prima~y In Vitro Anti-SRBC
Responses of DBA/2 B Cell Suspensions. After fusion, hybrids were detected in 115 of 288 wells plated, and the supernates from these positive wells were screened for B cellactivating capacities. Approximately one-half of these supernates manifested little or no positive biological effects, about one-third displayed low-to-moderate biological activity, and a small number demonstrated rather potent biological effects when tested, as shown below.
The experiment portrayed in Fig. 1 illustrates the activities of two high AEFsecreting hybridomas in terms of their B cell-activating properties. In the left panel are shown the good in vitro responses of untreated DBA/2 spleen cells to SRBC and the abrogation of such responses after treatment of such cells with anti-Thy-l.2 plus C. In the right panel, the vertical bar illustrates the capacity of a conventional AEF preparation to restore totally the responses of T cell-depleted B cells after stimulation with SRBC. In addition, the B cell-activating effects of five different hybridoma supernates, tested at three different concentrations each, are illustrated. The hybridoma supernates tested were obtained in serum-free conditions by washing the cultured hybridoma cells, replating them in serum-free medium, and harvesting the culture supernates after 24 h. It is clear that supernates from those hybridomas designated 27 and 34 display strong B cell-activating effects, which dilute out in a dose-related fashion. Supernate from the hybridoma designated hybridoma 18 displayed modest B cell-activating effects only at the highest concentration tested, whereas supernates from hybridomas 31 and 10 are negative for such activity. Although not shown, culture supernates from the unfused parental line, BW 5147, likewise failed to display any B cell-activating properties in these cultures. Hybridomas 27 and 34 were selected for further experimentation and have now been maintained in culture for ~ 1 yr, retaining their biological activity. 
CONCENTRATION OF
Biological Effects on B and T Lymphocytes of AEF Hybridoma Supernate Obtained After Alloantigen Restimulation.
Because the AEF hybridomas were derived from T cell blasts generated after stimulation by alloantigens, we were interested in determining whether the hybridomas themselves displayed any responsiveness to additional stimulation with the original inducing alloantigen. Thus, cells of hybridoma 34 were cultured overnight in the presence of equal numbers of irradiated C3D2Fz target spleen cells, and the supernate was recovered from such stimulated hybridoma cultures and analyzed for biological activities on both B and T lymphocytes.
As shown in Fig. 2 , the supernate from such restimulated hybridoma cells displayed excellent B cell-reconstituting effects in in vitro antibody responses to TNP-SRBC (left panel), and perfectly clear T cell-activating properties as manifested by its ability to stimulate development of CTL in the absence of exogenous antigen (middle panel), and direct proliferation of unprimed T lymphocytes (right panel). It should be noted that these activities were obtained with a concentration of hybridoma supernate (1: 20) that is well below the activity threshold of supernates from the same hybridoma not restimulated with alloantigen (see also Fig. 1 ). Furthermore, it should be noted that the culture supernate of the unstimulated hybridoma failed to display B cell-or T cell-activating properties in this experiment when tested at the same dilution.
To ascertain whether the enhanced biological activity displayed by the culture supernate of the C3D2Ft-stimulated hybridoma reflects an antigen-specific event, we In order to verify that the AEF molecules detected in the T cell hybridoma supernates presented in this study were likewise Ia-positive, we investigated whether the activity of such molecules would be sensitive to the effects of anti-Ia antibodies.
The experiment summarized in Fig. 3 demonstrates that this is, indeed, the case. Anti-Thy-l. and this serum was devoid of any reactivity with A/J spleen cells in a C-dependent microcytotoxicity assay (not shown). As shown in panel A, cultures of such T cell-depleted A/J spleen cells exposed to a conventional AEF preparation develop good primary TNP-specific in vitro responses to TNP-SRBC. Incorporation of anti-Ia s antibodies has no effect on the capacity of this AEF preparation (also derived from DBA/2-activated T cells) in stimulating such B cell responses. In contrast, incorporation of antibodies specific for I-A a determinants substantially inhibits the activity of this AEF preparation on the A/J responder B cells.
As shown in panel B, AEF activity of serum-free supernate of hybridoma 34 is not significantly affected by the incorporation of normal mouse serum of B 10.A origin, whereas incorporation of anti-I-A a antibodies at the same concentration totally abolishes the B cell-activating properties of this AEF-secreting hybridoma. Control cultures of untreated (i.e., T cell-containing) A/J spleen cells developed good responses to TNP-SRBC, and these responses were not inhibited by the same anti-I-A a antibodies (Fig. 3, legend) .
Cloning of Hybridorna 34. Hybridoma 34 was cloned by plating an average of 0.8 hybridoma cells per fiat-bottom microtiter well (200 ~1) in the presence of heavily irradiated BALB/c thymocytes, which served as feeder cells. Growth of hybridoma cells was detected in 75% of the wells after 10-14 d, and, of these, about two-thirds contained single cell clones. These clones were transferred to 16-mm wells, grown to confluence, and their supernates were tested for induction of self-reactive CTL at a 1 : 10 final dilution. About 30% of the supernates displayed biological activity as evidenced by the resultant CTL activity, which was significantly above the background level of 51Cr release. Furthermore, the culture supernates derived from some of these clones were mitogenic for peanut agglutinin-nonagglutinable (PNA-) thymocytes, indicating that the hybridoma-derived AEF is indeed mitogenic for unprimed T cells. Thus, whereas the level of [aH]TdR uptake by 2 × 10 -5 unstimulated PNA-thymocytes in a 5-d assay was 171 cpm, stimulation by the supernate of one of the clones was 3,247 and 14,716 cpm at 1:20 and 1:10 dilutions, respectively.
Cell Sorter Analysis of Ia Determinants on AEF-secreting Hybridomas. In view of our findings that conventionally derived AEF bears Ia determinants (2) and that the biological activity of both the conventional and the hybridoma-derived AEF preparations is inhibited by specific anti-Ia antibodies, it was of importance to determine whether the hybridoma cells express Ia antigens of the normal T cell partner, i.e., Iad. 
Discussion
The technique of somatic cell hybridization as refined by KiJhler and Milstein for immunologically relevant cells (23) , has provided a revolutionary tool for studies on lymphocyte biology. This technology, developed initially for the construction of hybrid cell lines of the B cell lineage, subsequently was extended to the construction of T cell hybridomas by fusion of either normal or activated T cells with established T lymphoma lines (16, 24, 25) . Although the success of hybridization with such T lymphoma lines was verified by appropriate codominant expression of certain cell surface markers characteristic of the phenotypes of each of the respective partner cells, these early studies failed to demonstrate, where analyzed, expression of functional T cell characteristics (16, 24, 25) . Subsequently, several laboratories have been successful in constructing T cell hybridomas expressing T cell function of the nonlymphoma partner as manifested by the active secretion of soluble mediators capable of exerting immunoregulatory effects (26) (27) (28) (29) (30) (31) (32) (33) ; with one exception (27) , these successful fusions have utilized the AKR T lymphoma line designated BW5147. All of these latter studies have been concerned with the construction ofT cell hybridomas producing T cell factors capable of suppressing immune responses either in an antigen-specific manner for humoral responses (26, 27, (29) (30) (31) or delayed-type hypersensitivity responses (32), or in an antigen nonspecific manner for humoral responses (33) or selective for antibody responses of the IgE class (28) . A recent report (34) described the construction of a T hybridoma line capable of secreting biologically active factors effective in stimulating hematopoietic colony growth and B cell responses in vitro; however, this line did not secrete such factors spontaneously and required stimulation by concanavalin A to release active molecules into culture supernates. The present report constitutes, therefore, the first description of the successful construction of hybrid T cell lines spontaneously secreting a biologically active factor capable of enhancing immune responses, namely AEF.
The construction of AEF-secreting hybridomas was accomplished by fusing the BW5147 cell line with alloantigen-activated T cell blasts obtained after consecutive in vivo and in vitro activation steps. T cell blasts obtained in this manner yielded a relatively high fusion frequency with about one-third of such hybrids manifesting some degree of AEF-like biological activity. Two of the hybridomas secreting rather substantial quantities of AEF were chosen for the analyses presented herein. That these two lines secreting AEF, are indeed, true hybrids was verified by demonstrating codominant expression of the relevant allelic forms of Thy-1 antigens and the serological determinants of H-2 contributed by each of the respective fused partner cells.
The supernates obtained from hybridomas 27 and 34 displayed typical functional characteristics ascribed to AEF. Thus, these hybridoma supernates were capable of activating B lymphocytes to respond to either SRBC or TNP-SRBC in cultures depleted of helper T lymphocytes normally required for such responses. Moreover, the typical T cell-activating properties of AEF, as described in recent studies from this laboratory (8) (9) (10) (11) (12) (13) , such as the ability to stimulate autonomous development of selfspecific CTL and the capacity to directly stimulate T cell proliferation, were likewise present in these hybridoma supernates. The fact that the biological activities of AEF on both B and T lymphocyte targets coexisted in the same hybridoma supernates suggests, but does not prove, that these two distinct activities may be mediated by the same molecule; definitive proof on this issue must await complete cloning of these hybridoma lines and isolation to homogeneity of the active molecules secreted by them.
Evidence supporting the fact that the activities observed were, indeed, mediated by AEF, and not by one or more artifactual components of the cultured lines, can be summarized as follows: (a) supernates obtained for testing in the biological assays performed were free of all exogenous serum and/or protein constituents; (b) supernates from the parent thymoma line cultured alone, as well as from numerous hybrids constructed from the same starting cell population, were devoid of any detectable AEF activity (moreover, such negative supernates were unable to suppress positive AEF-mediated biological effects, not shown); and (c) the AEF activities displayed by positive hybridomas, like those same activities exhibited by conventional preparations of AEF, could be abrogated by exposure to specific anti-Ia antibodies, thus verifying the expression of Ia determinants on the relevant molecules. It is interesting in the latter regard that most of the functional T cell hybridomas that have been successfully constructed, including those reported here, are lines capable of producing soluble mediators that bear I region determinants.
Another new finding described in the present report is the ability of these AEFsecreting hybridoma lines to respond to specific alloantigen stimulation. Responsiveness was verified by induced proliferation of hybridoma 34 after reexposure to fresh, irradiated C3D2F1 target cells many months after initial fusion. This proliferative burst was accompanied by secretion of significantly increased quantities of AEF into supernates of such stimulated cultures, effective in exerting both B cell-and T cellactivating effects at a dilution factor well below detectable activities in supernates of unstimulated cultures of the same line. This contrasts with the failure of K6hler et al. (25) to observe either specific responsiveness or production of AEF in hybridomas constructed from MLR-stimulated T cells and the same BW5147 thymoma line. The differences between their results and ours reported here most likely relate to the degree of T cell activation used in obtaining the blasts for fusion. In their study, T cells obtained from primary MLR activation were employed, whereas in the present studies we utilized T cell blasts activated by consecutive in vivo and in vitro stages. Whereas our hybridoma is functionally responsive to specific antigen stimulation as evidenced by proliferation and increased secretion of AEF, it has not yet been determined whether our lines possess any specific cytolytic activities.
In addition to the results presented here, studies currently being conducted in collaboration with W. H. Fridman and colleagues have shown that both hybridomas 27 and 34 express Fc receptors (FcR) specific for immunoglobulins of the IgG class (FcRy) (W. H. Fridman, et al. Manuscript in preparation.). Moreover, like a T cell hybridoma constructed by these same investigators that is also FcRy positive (33), both hybridoma 27 and 34 secrete immunoglobulin-binding factor (IBF) activity (35) (36) (37) , and their line (designated T2D4) appears to secrete AEF-like enhancing activity. It should be emphasized, however, that preferential expression of either AEF-enhancing or IBF-suppressive activities by the T2D4 and our hybridoma lines depends critically on the culture conditions used for the preparation of the biologically active supernates. Although exerting opposite, suppressive activity on T cell-dependent in vitro antibody responses, IBF, like AEF, has recently been found to bear Ia determinants (37) . Details of these studies will be published elsewhere in the near future. It is interesting to find these two opposing biological activities, both of which are Ia positive, synthesized and secreted by the same T cell hybridoma lines, although the possible relevance of these findings will not be discussed here.
It is also worth noting one other point about the AEF-secreting hybridomas 27 and 34 lines, namely that the supernate of both lines is totally devoid of detectable interferon activity. In a recent extensive analysis of the possible contributions that interferon may make to the biological activities manifested by AEF preparations obtained in the conventional manner, we have shown that removal of interferon contaminants from AEF by hydrophobic chromatography does not result in a corollary diminution of AEF activities, but rather tends to increase the expression of AEF effects (20) . The fact that the AEF-secreting hybridomas described here are totally negative for interferon production proves beyond doubt that interferon is not responsible for any of the activities ascribed to AEF.
Finally, it is worth noting that because these T cell hybridomas secrete Ia-positive AEF molecules, our original contention that AEF is indeed derived from T cells (1, (4) (5) (6) , a position contested somewhat by certain of the results of Delovitch et al. (38, 39) , has been validated. Biochemical analysis will be undertaken once sufficient quantities of the cloned AEF-secreting hybridomas are available.
These AEF-secreting hybridoma lines, like others of a similar nature, should be invaluable for allowing future studies on the molecular biology of these important immunoregulatory molecules.
Summary
T cell hybridoma lines were constructed by fusion of DBA/2 alloantigen-activated T cell blasts with the AKR thymoma line BW5147. Certain of the hybridomas prepared in this manner secreted spontaneously into their culture supernates biologically active molecules that displayed B cell-and T cell-activating properties characteristic of allogeneic effect factor (AEF). Cell surface phenotype analysis documented that the hybridomas were, indeed, somatic cell hybrids between the two respective partner cells used for fusion. The B cell-activating properties of these hybridoma supernates was demonstrated by their capacity to stimulate T cell-depleted spleen cells to respond in vitro to T-dependent antigens. The T cell-activating properties of these hybridoma supernates was verified by their capacity to stimulate autonomous development of self-specific cytotoxic T lymphocytes and by their capacity to exert mitogenic effects on unprimed T cells. The biologically active molecules secreted by these hybridomas were, like conventional AEF, inhibitable by specific anti-Ia antibodies thus indicating the presence of Ia determinants on the relevant hybridoma products. Finally, these AEF-secreting hybridomas could be stimulated to proliferate and to secrete increased quantities of AEF when exposed to the specific alloantigenbearing target cells to which the T cell blasts had been originally sensitized.
